top | item 10544522

(no title)

7Figures2Commas | 10 years ago

> Theranos often drew the same employee’s blood twice, first with blood from a finger prick and then the traditional method of a needle in the arm, according to one former Safeway executive.

> The former executive said he worried that Theranos’s finger-prick process was still a work in progress. “If the technology is fully developed, why would you need to do a venipuncture?” this person said, using the term for a traditional blood draw.

> The concerns deepened when Theranos’s test results for several Safeway employees differed from the results the same employees got from other laboratories, according to the former executive. Another former Safeway executive confirmed those recollections.

> Theranos also backed away from putting its blood analyzers in Safeway’s clinics so patients could get the results quickly, the current and former executives said.

> Instead, Theranos said blood samples collected at Safeway would have to be shipped to a central lab for analysis, according to the former executives.

Wow. The Theranos story just keeps getting worse.

discuss

order

danieltillett|10 years ago

Yep. I think this unicorn has a broken leg.

AJ007|10 years ago

Where is the line between grossly exaggerating ones product and criminal fraud drawn?

Personally I view things where you give someone a false health diagnosis to be among the most egregious deceptions possible, a step beyond running a Ponzi scheme and in line with other things where users are severely hurt or killed.

auvi|10 years ago

If Theranos is still valued at $9 billion, then it is almost a decacorn. We have to see what happens to its nine unicorn (or cat, pun intended) lives.

AJ007|10 years ago

[deleted]